{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:47:35Z","timestamp":1750481255579},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1987,2,1]],"date-time":"1987-02-01T00:00:00Z","timestamp":539136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1987,2]]},"DOI":"10.1007\/bf01806695","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T23:35:39Z","timestamp":1119915339000},"page":"61-67","source":"Crossref","is-referenced-by-count":8,"title":["Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues"],"prefix":"10.1007","volume":"9","author":[{"given":"Rajeshwari R.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas K.","family":"DasGupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806695_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","volume":"25","author":"BJA Furr","year":"1984","unstructured":"Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmaceut Ther 25: 127\u2013205, 1984","journal-title":"Pharmaceut Ther"},{"key":"BF01806695_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2964(80)90348-5","volume":"16","author":"JC Allegra","year":"1980","unstructured":"Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff K, Do HT, Aitken SC, Warren R: Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 16: 323\u2013331, 1980","journal-title":"Eur J Cancer"},{"key":"BF01806695_CR3","first-page":"249","volume":"41","author":"KB Horwitz","year":"1985","unstructured":"Horwitz KB, Wei L, Sedlacek SM, D'arville CN: Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog Hormone Res 41: 249\u2013316, 1985","journal-title":"Recent Prog Hormone Res"},{"key":"BF01806695_CR4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0006-291X(84)90289-4","volume":"123","author":"LJ Brandes","year":"1984","unstructured":"Brandes LJ, Hermonat MW: A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomes. Biochem Biophys Res Commun 123: 724\u2013728, 1984","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01806695_CR5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/endo-113-3-1167","volume":"113","author":"JH Clark","year":"1983","unstructured":"Clark JH, Winneker RC, Guthrie SC, Markaverich BM: An endogeneous ligand for the triphenylethylene antiestrogen binding site. Endocrinology 113: 1167\u20131169, 1983","journal-title":"Endocrinology"},{"key":"BF01806695_CR6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0006-291X(85)90271-2","volume":"126","author":"LJ Brandes","year":"1985","unstructured":"Brandes LJ, MacDonald LM, Bogdanovic RP: Evidence that the antiestrogen binding site is a histamine or histamine-like receptor. Biochem Biophys Res Commun 126: 965\u2013970, 1985","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01806695_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-12-452812-3.50015-4","volume":"XII","author":"JH Clark","year":"1985","unstructured":"Clark JH, Winneker RC, Markaverich BM: Estrogen and antiestrogen binding sites: relation to the estrogen receptor and biological response. Biochemical Actions of Hormones, vol XII, 1985, pp 353\u2013383","journal-title":"Biochemical Actions of Hormones"},{"key":"BF01806695_CR8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/endo-115-1-420","volume":"115","author":"PR Murphy","year":"1984","unstructured":"Murphy PR, Butts C, Lazier CB: Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: Evidence for an endogenous ligand. Endocrinology 115: 420\u2013426, 1984","journal-title":"Endocrinology"},{"key":"BF01806695_CR9","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/S0021-9258(18)32845-X","volume":"258","author":"OL Kon","year":"1983","unstructured":"Kon OL: An antiestrogen binding protein in human tissues. J Biol Chem 258: 3173\u20133177, 1983","journal-title":"J Biol Chem"},{"key":"BF01806695_CR10","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/S0021-9258(17)43033-X","volume":"259","author":"CKW Watts","year":"1984","unstructured":"Watts CKW, Murphy LC, Sutherland RL: Micosomal binding sites for nonsteroidal antiestrogen in MCF-7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J Biol Chem 259: 4223\u20134229, 1984","journal-title":"J Biol Chem"},{"key":"BF01806695_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000225860","volume":"41","author":"RG Mehta","year":"1984","unstructured":"Mehta RG, Cerny WL, Moon RC: Distribution of antiestrogen specific binding sites in normal and neoplastic mammary gland. Oncology 41: 387\u2013392, 1984","journal-title":"Oncology"},{"key":"BF01806695_CR12","first-page":"307","volume":"5","author":"M Ferno","year":"1985","unstructured":"Ferno M, Borg A: Antiestrogen binding sites in human breast cancer biopsies. Anticancer Res 5: 307\u2013312, 1985","journal-title":"Anticancer Res"},{"key":"BF01806695_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0277-5379(86)90047-7","volume":"22","author":"CL Lim","year":"1986","unstructured":"Lim CL, Walker MJ, Mehta RR, DasGupta TK: Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 22: 583\u2013587, 1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806695_CR14","first-page":"3094","volume":"43","author":"MA Miller","year":"1983","unstructured":"Miller MA, Katzenellenbogen BS: Characterization and quantitation of antiestrogen binding sites in estrogen receptor positive and negative human breast cancer cell lines. Cancer Res 43: 3094\u20133100, 1983","journal-title":"Cancer Res"},{"key":"BF01806695_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-4731(84)90197-3","volume":"20","author":"AE Wakeling","year":"1984","unstructured":"Wakeling AE, Valcaccia B, Newboult E, Green LR: Nonsteroidal antiestrogens \u2014 receptor binding and biological response in rat uterus, rat mammary carcinoma and breast cancer cells. J Steroid Biochem 20: 111\u2013120, 1984","journal-title":"J Steroid Biochem"},{"key":"BF01806695_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01806018","volume":"5","author":"BS Katzenellenbogen","year":"1985","unstructured":"Katzenellenbogen BS, Mullick A, Miller MA, Sheen YY: Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Breast Cancer Res Treat 5: 231\u2013243, 1985","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806695_CR17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660\u2013672, 1949","journal-title":"Ann NY Acad Sci"},{"key":"BF01806695_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr A, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265\u2013275, 1951","journal-title":"J Biol Chem"},{"key":"BF01806695_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4615-6571-0_3","volume-title":"Breast Cancer \u2014 4. Advances in Research and Treatment","author":"P Mauvais-Jarvis","year":"1981","unstructured":"Mauvais-Jarvis P, Sitruk-Ware R, Kutenn F: Benign breast disease. In: McGuire WL (ed): Breast Cancer \u2014 4. Advances in Research and Treatment. Plenum Press, New York, 1981, pp 51\u201394"},{"key":"BF01806695_CR20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0014-2964(80)90172-3","volume":"16","author":"RL Sutherland","year":"1980","unstructured":"Sutherland RL, Murphy LC: The binding of tamoxifen to human mammary carcinoma cytosol. Eur J Cancer 16: 1141\u20131148, 1980","journal-title":"Eur J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806695.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806695\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T12:14:09Z","timestamp":1626092049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,2]]}},"alternative-id":["BF01806695"],"URL":"https:\/\/doi.org\/10.1007\/bf01806695","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,2]]}}}